Effectiveness of various therapy regimens for patients with pulmonary Langerhans cell histiocytosis during long-term follow-up

Conclusion: The use of a combination of SCS+cytostatic drug is more effective than monotherapy with SCS. Chemotherapy can improve the prognosis of the course of the disease in patients with rapid progression.

http://erj.ersjournals.com/cgi/content/short/54/suppl_63/OA2142?rss=1

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Zinchenko, A., Novikova, L., Ilkovich, M. Tags: Rare ILD/DPLD Source Type: research